Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antagonist activity at P2Y4R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Antagonist activity at human P2Y4R expressed in HEK293 cells assessed as inhibition of UTP-induced IP3 production preincubated for 0.5 hrs followed by UTP stimulation by ELISA
PRESTO-Tango GPCRome screening (P2RY4)
SummaryRelated BioAssays by Target
P2Y CEREP ligand profiling
P2Y-purinergic receptor CEREP ligand profiling
P2Y Ligand binding assay
Antagonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as inhibition of UTP-induced intracellular calcium influx at 10 to 100 uM preincubated for 20 mins followed by UTP addition measured at 0.4 secs interval for 60 times by Oregon Green BAPTA-1/AM dye-based fluorescence assay
Assay data:36 Tested
Antagonist activity against human P2Y4 in human 1321N1 cells assessed as effect on calcium transients
Agonist activity at human P2Y4 in human 1321N1 cells assessed as effect on calcium transients
Antagonist activity at human P2Y4R expressed in human 1321N1 cells assessed as inhibition of UTP-induced calcium mobilization at 10 uM by PDSP assay
Assay data:3 Tested
Agonist activity at human P2Y4R expressed in human 1321N1 cells assessed as calcium mobilization at 10 uM by PDSP assay
Antagonist activity human P2Y4R expressed in human 1321N1 cells assessed as inhibition of UTP-induced [3H]inositol phosphate accumulation after 30 mins by liquid scintillation counting method
Inhibition of human P2Y4 assessed as reduction in agonist-induced intracellular Ca2+ concentration at 10 uM pre-incubated for 30 mins before agonist addition by FLUO-4 AM dye based fluorescence assay
Antagonist activity at human P2Y4 receptor expressed in AD293 cells assessed as inhibition of UTP-induced inositol-1-phosphate accumulation at 0.1 to 100 uM
Assay data:8 Tested
Agonist activity at human P2Y4 receptor expressed in AD293 cells assessed as inositol-1-phosphate accumulation at 0.1 to 100 uM
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Non-competitive antagonist activity at human P2Y4 receptor transfected in human 1321N1 cells assessed as inhibition of UTP-activated intracellular calcium mobilization at 15 uM preincubated for 30 mins followed by UTP addition by fluo-4-dye based fluorescence assay
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Antagonist activity at human P2Y4 receptor transfected in human 1321N1 cells assessed as inhibition of UTP-activated intracellular calcium mobilization at 100 uM preincubated for 30 mins followed by UTP addition by fluo-4-dye based fluorescence assay
Assay data:6 Tested
Antagonist activity at human P2Y4 receptor transfected in human 1321N1 cells assessed as inhibition of UTP-activated intracellular calcium mobilization at 30 uM preincubated for 30 mins followed by UTP addition by fluo-4-dye based fluorescence assay
Assay data:7 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on